chuminhua2019-10-23 23:33
10/22,Trovagene公$Trovagene(TROV)$ 宣布,其在研PLK1抑制剂onvansertib(PCM-075),与Folfiri,Avastin(bevacizumab)联合,作为二线疗法在治疗携带KRAS基因突变的转移性结直肠癌(CRC)患者的1b/2期临床试验中,取得积极的试验初期数据。在第一批患者的分析中,观察到肿瘤KRAS基因突变负荷水...查看全文
牛唐2019-08-21 14:21
$Ardelyx(ARDX)$ $Trovagene(TROV)$ 放量上涨的runup走势,9月13号,ARDX的药物Ibresla在IBS适应症方面会有审批,9月底前计划公布高磷酸盐血症方面的三期topline data;trov是在8月24日计划公布 Onvansertib 与Zytiga的二期数据$复星医药(SH600196)$查看全文
越炒股越美2019-04-25 14:53
【汇众医疗】4月23日医药股盘点:6支生物制药股势头强劲,上涨幅度均高于15%
$Atossa Genetics(ATOS)$$Trovagene(TROV)$ $Athersys(ATHX)$ 4月23日股市收盘时,6支生物制药公司股票上涨,涨幅均高于15%。而研发乳腺癌药物的Atossa Genetics以3.48美元收盘,上涨22.97%,涨幅最大。研究罕见病药...查看全文
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-08-16 AccNo: 0001193125-18-250467 Size: 37 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-08-15 AccNo: 0001193125-18-249436 Size: 35 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-08-03 AccNo: 0001193125-18-238556 Size: 137 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-08-03 AccNo: 0001193125-18-238556 Size: 137 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-03 AccNo: 0001628280-18-010424 Size: 4 MB 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-08-01 AccNo: 0001193125-18-234330 Size: 49 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-08-01 AccNo: 0001193125-18-234330 Size: 49 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-07-17 AccNo: 0001193125-18-219245 Size: 22 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$TrovaGene, Inc.(TROV)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-07-13 AccNo: 0001193125-18-217931 Size: 56 KB 网页链接
$TrovaGene, Inc.(TROV)$ 8-K - Current report Filed: 2018-07-10 AccNo: 0001193125-18-215157 Size: 48 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接